Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Nature Neuroscience

• Publication date

  2022-09-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41593-022-01160-zPMID 36171425PMCID PMC9682545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci

  2022cited by this paper
• Exploiting the GTEx resources to decipher the mechanisms at GWAS loci

  2021cited by this paper
• Clinical laboratory test-wide association scan of polygenic scores identifies biomarkers of complex disease

  2021cited by this paper
• Genome-wide association study and multi-trait analysis of opioid use disorder identifies novel associations in 639,709 individuals of European and African ancestry.

  2021cited by this paper
• Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond

  2021cited by this paper
• Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction

  2021cited by this paper
• Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry

  2021cited by this paper
• GWAS of allometric body-shape indices in UK Biobank identifies loci suggesting associations with morphogenesis, organogenesis, adrenal cell renewal and cancer

  2021cited by this paper
• Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology

  2021cited by this paper
• Activity in projection neurons from prelimbic cortex to the PVT is necessary for retrieval of morphine withdrawal memory.

  2021cited by this paper
• Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement.

  2020cited by this paper
• Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ethnic meta-analysis

  2020cited by this paper
• Substance Abuse and Mental Health Services Administration

  2020cited by this paper
• Opioid use disorder

  2020cited by this paper
• Genome-wide association analysis of opioid use disorder: A novel approach using clinical data.

  2020cited by this paper
• A large-scale genome-wide association study meta-analysis of cannabis use disorder

  2020cited by this paper
• Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study

  2020cited by this paper
• Ensembl 2021

  2020cited by this paper
• Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018

  2020cited by this paper
• Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts

  2020cited by this paper
• Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits

  2020cited by this paper
• Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study.

  2020cited by this paper
• A review of opioid addiction genetics.

  2019cited by this paper
• The GTEx Consortium atlas of genetic regulatory effects across human tissues

  2019cited by this paper
• Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium

  2019cited by this paper
• Harmonizing Genetic Ancestry and Self-identified Race/Ethnicity in Genome-wide Association Studies.

  2019cited by this paper
• Accurate, scalable and integrative haplotype estimation

  2019cited by this paper
• Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders.

  2019cited by this paper
• Widespread dose-dependent effects of RNA expression and splicing on complex diseases and traits

  2019cited by this paper
• Opioid Use Disorder

  2019cited by this paper
• Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression

  2019cited by this paper
• Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions

  2019cited by this paper
• Identification of common genetic risk variants for autism spectrum disorder

  2019cited by this paper
• Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.

  2019cited by this paper
• Current Understanding of the Neurobiology of Opioid Use Disorder: an Overview

  2019cited by this paper
• Genomic SEM Provides Insights into the Multivariate Genetic Architecture of Complex Traits

  2019cited by this paper
• Complex-Traits Genetics Virtual Lab: A community-driven web platform for post-GWAS analyses

  2019cited by this paper
• Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood

  2018cited by this paper
• Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use

  2018cited by this paper
• Polygenic prediction via Bayesian regression and continuous shrinkage priors

  2018cited by this paper
• Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017

  2018cited by this paper
• Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals

  2018cited by this paper
• GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability

  2018cited by this paper
• Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder

  2018cited by this paper
• Integrating predicted transcriptome from multiple tissues improves association detection

  2018cited by this paper
• Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis

  2018cited by this paper
• Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans

  2018cited by this paper
• Genetic effects on gene expression across human tissues

  2017cited by this paper
• An xQTL map integrates the genetic architecture of the human brain’s transcriptome and epigenome

  2017cited by this paper
• Functional mapping and annotation of genetic associations with FUMA

  2017cited by this paper
• Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types

  2017cited by this paper
• Million Veteran Program: A mega-biobank to study genetic influences on health and disease.

  2016cited by this paper
• Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia

  2016cited by this paper
• Fast set-based association analysis using summary data from GWAS identifies novel gene loci for human complex traits

  2016cited by this paper
• Transethnic genetic correlation estimates from summary statistics

  2016cited by this paper
• Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics

  2016cited by this paper
• Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets

  2016cited by this paper
• Next-generation genotype imputation service and methods

  2016cited by this paper
• Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis

  2015cited by this paper
• Partitioning heritability by functional annotation using genome-wide association summary statistics

  2015cited by this paper
• Evidence of CNIH3 involvement in opioid dependence

  2015cited by this paper
• MAGMA: Generalized Gene-Set Analysis of GWAS Data

  2015cited by this paper
• A global reference for human genetic variation

  2015cited by this paper
• Pharmacogenetics of OPRM1.

  2014cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• LD Score regression distinguishes confounding from polygenicity in genome-wide association studies

  2014cited by this paper
• Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways.

  2014cited by this paper
• Second-generation PLINK: rising to the challenge of larger and richer datasets

  2014cited by this paper
• Vital Signs: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women — United States, 1999–2010

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective.

  2012cited by this paper
• Involvement of NCAM and FGF receptor signaling in the development of analgesic tolerance to morphine.

  2011cited by this paper
• GCTA: a tool for genome-wide complex trait analysis.

  2011cited by this paper
• Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++

  2010cited by this paper
• METAL: fast and efficient meta-analysis of genomewide association scans

  2010cited by this paper
• Integrating common and rare genetic variation in diverse human populations

  2010cited by this paper
• The NIH Roadmap Epigenomics Mapping Consortium

  2010cited by this paper
• Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence.

  2008cited by this paper
• Transcriptional profiling of C57 and DBA strains of mice in the absence and presence of morphine

  2007cited by this paper
• Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.

  2007cited by this paper
• Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.

  2006cited by this paper
• Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.

  2003cited by this paper
• Genetics of two μ opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

  1999cited by this paper
• Addiction is a brain disease, and it matters.

  1997cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin.

  1993cited by this paper

• Building epigenetic risk scores of opioid use disorder: Insights from human postmortem brain data

  2026cites this paper
• Advancing substance use disorder biology by studying underlying gene x environment interactions.

  2026cites this paper
• Large-scale behavioral characterization of oxycodone self-administration in heterogeneous stock rats reveals initial analgesic effects are associated with addiction-like behaviors.

  2026cites this paper
• Substance use disorders exhibit unique and disorder specific genetic associations with externalizing and internalizing psychopathology

  2026cites this paper
• A Joint Survival Modeling and Therapy Knowledge Graph Framework to Characterize Opioid Use Disorder Trajectories

  2026cites this paper
• Optimizing Control Definitions in Opioid Use Disorder Genetic Research Using Electronic Health Records

  2026cites this paper
• Polygenic risk scores reveal genetic underpinnings of comorbidity betweensubstance use disorders and ADHD.

  2026cites this paper
• Leveraging Genomic Data to Examine the Causal Impact of Alcohol, Tobacco, Cannabis, and Opioid Use on Biological and Cognitive Ageing

  2025cites this paper
• Establishing Best Practices for Clinical GWAS: Tackling Imputation and Data Quality Challenges

  2025cites this paper
• Polygenic risk and childhood adversity as moderators of drug and alcohol withdrawal symptoms.

  2025cites this paper
• Integrating HiTOP and RDoC frameworks Part I: Genetic architecture of externalizing and internalizing psychopathology

  2025cites this paper
• Cornichon Homolog-3 (Cnih3) deletion impairs spatial memory, reward-cue association, and fentanyl self-administration behavior

  2025cites this paper
• Similarities and Differences in Genetics.

  2025cites this paper
• Genetic Architecture and Risk of Childhood Maltreatment Across 5 Psychiatric Diagnoses.

  2025cites this paper
• Morphine reprograms brain-derived extracellular vesicles from cargo linked to synaptic remodelling in the prefrontal cortex

  2025cites this paper
• Incidence of alternative splicing associated with sex and opioid effects in the axon guidance pathway

  2025cites this paper
• Utility of Candidate Genes From an Algorithm Designed to Predict Genetic Risk for Opioid Use Disorder

  2025cites this paper
• Transdiagnostic and Disorder-Level GWAS Enhance Precision of Substance Use and Psychiatric Genetic Risk Profiles in African and European Ancestries.

  2025cites this paper
• Elucidating the role of FBXW4 in osteoporosis: integrating bioinformatics and machine learning for advanced insight

  2025cites this paper
• Sex-Specific Concordance of Striatal Transcriptional Signatures of Opioid Addiction in Human and Rodent Brains

  2025cites this paper
• Understanding the comorbidities among psychiatric disorders, chronic low-back pain, and spinal degenerative disease using observational and genetically informed analyses

  2025cites this paper
• Psychiatric genetics in the diverse landscape of Latin American populations

  2025cites this paper
• Associations of childhood adversity and substance use disorder polygenic scores with disorder severity and diagnostic criteria

  2025cites this paper
• Genome-wide meta-analyses of cross substance use disorders in diverse populations

  2025cites this paper
• Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response

  2025cites this paper
• Whole-exome sequencing study of opioid dependence offers novel insights into the contributions of exome variants

  2025cites this paper
• Understanding the Comorbidities Among Psychiatric Disorders, Chronic Low Back Pain, and Spinal Degenerative Disease Using Observational and Genetically Informed Analyses

  2025cites this paper
• Genetic and Epigenetic Approaches to Opioid Use Disorder

  2025influential citation
• Scoping review of associations between cytochrome P450 3A4/5 single nucleotide polymorphisms and risk factors for fentanyl overdose

  2025cites this paper
• Identification of potential therapeutic targets for problematic alcohol use using multi-omics data

  2025cites this paper
• Spatial transcriptomics reveals distinct cell type dynamics following opioid dependence in mice with the common human variant in the μ-opioid receptor, Oprm1 A118G

  2025cites this paper
• An emerging multi-omic understanding of the genetics of opioid addiction

  2024influential citation
• Genomic factors associated with substance use disorder relapse: A critical review

  2024cites this paper
• Impulsivity facets and substance use involvement: insights from genomic structural equation modeling

  2024cites this paper
• Multi-omic network analysis identifies dysregulated neurobiological pathways in opioid addiction

  2024cites this paper
• Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records

  2024cites this paper
• Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases

  2024cites this paper
• Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and medical traits

  2024cites this paper
• Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders.

  2024cites this paper
• Genetic and non-genetic predictors of risk for opioid dependence.

  2024cites this paper
• Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders

  2024influential citation
• Disentangling the shared genetics of ADHD, cannabis use disorder and cannabis use and prediction of cannabis use disorder in ADHD

  2024cites this paper
• A Multivariate Genome-Wide Association Study Reveals Neural Correlates and Common Biological Mechanisms of Psychopathology Spectra

  2024influential citation
• Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes

  2024cites this paper
• Divergent gene expression patterns in alcohol and opioid use disorders lead to consistent alterations in functional networks within the Dorsolateral Prefrontal Cortex

  2024cites this paper
• Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample

  2024cites this paper
• Candidate Genes from an FDA-Approved Algorithm Fail to Predict Opioid Use Disorder Risk in Over 450,000 Veterans

  2024cites this paper
• A single-nucleus transcriptomic atlas of medium spiny neurons in the rat nucleus accumbens

  2024influential citation
• The genetic landscape of substance use disorders

  2024cites this paper
• Differential etiologic associations of heroin use and prescription opioid misuse with psychopathology.

  2024cites this paper
• Generalized genetic liability to substance use disorders

  2024influential citation
• Gene × environment effects and mediation involving adverse childhood events, mood and anxiety disorders, and substance dependence

  2024cites this paper
• Shared genetics of ADHD, cannabis use disorder and cannabis use and prediction of cannabis use disorder in ADHD

  2024influential citation
• Shared and unique 3D genomic features of substance use disorders across multiple cell types

  2024cites this paper
• Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and somatic traits

  2024cites this paper
• Genome-wide meta-analyses of cross substance use disorders in European, African, and Latino ancestry populations

  2024influential citation
• A single-nucleus transcriptomic atlas of medium spiny neurons in the rat nucleus accumbens

  2024cites this paper
• The genetic architecture of substance use and its diverse correlations with mental health traits.

  2024cites this paper
• Whole-exome sequencing study of opioid dependence offers novel insights into the contributions of exome variants

  2024cites this paper
• A genome-wide Association study of the Count of Codeine prescriptions

  2024influential citation
• Sex and genetic background influence intravenous oxycodone self-administration in the hybrid rat diversity panel

  2024cites this paper
• Genetic Associations of Persistent Opioid Use After Surgery Point to OPRM1 but Not Other Opioid‐Related Loci as the Main Driver of Opioid Use Disorder

  2024cites this paper
• Sex-specific Concordance of Striatal Transcriptional Signatures of Opioid Addiction in Human and Rodent Brains

  2024cites this paper
• Considerations for the application of polygenic scores to clinical care of individuals with substance use disorders

  2024influential citation
• A review of the genomics of neonatal abstinence syndrome

  2023cites this paper
• Multi-ancestry study of the genetics of problematic alcohol use in >1 million individuals

  2023cites this paper
• Genome-wide analyses reveal shared genetic architecture and novel risk loci between opioid use disorder and general cognitive ability.

  2023cites this paper
• Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals

  2023cites this paper
• Opioid Trail: Tracking Contributions to Opioid Use Disorder from Host Genetics to the Gut Microbiome.

  2023cites this paper
• Adverse Childhood Events, Mood and Anxiety Disorders, and Substance Dependence: Gene x Environment Effects and Moderated Mediation

  2023cites this paper
• Adverse Childhood Events, Mood and Anxiety Disorders, and Substance Dependence: Gene X Environment Effects and Moderated Mediation

  2023cites this paper
• Identification of the role of immune-related genes in the diagnosis of bipolar disorder with metabolic syndrome through machine learning and comprehensive bioinformatics analysis

  2023cites this paper
• Predicting Heterogeneity in Patient Response to Morphine Treatment for Neonatal Opioid Withdrawal Syndrome

  2023cites this paper
• Identifying Genetic Loci and Phenomic Associations of Substance Use Traits: A Multi-trait Analysis of GWAS (MTAG) study.

  2023influential citation
• Does Polygenic Risk for Substance-Related Traits Predict Ages of Onset and Progression of Symptoms?

  2023influential citation
• Multi‐omics cannot replace sample size in genome‐wide association studies

  2023cites this paper
• Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomes

  2023cites this paper
• Integrating human brain proteomic data with genome-wide association study findings identifies novel brain proteins in substance use traits

  2022cites this paper
• Substance use and common contributors to morbidity: A genetics perspective

  2022cites this paper
• Accelerating Opioid Use Disorders Research by Integrating Multiple Data Modalities

  2022cites this paper
• Novel digital approaches to the assessment of problematic opioid use

  2022cites this paper
• The Genetically Informed Neurobiology of Addiction (GINA) model

  2022cites this paper
• Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program

  2022cites this paper
• Polygenic Risk for Substance-Related Traits Predicts Substance Use Onset and Progression: Sex and Population Group Differences

  2022cites this paper
• Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression

  2022cites this paper
• Identification of candidate genes for developmental colour agnosia in a single unique family

  2021cites this paper
• Becker Digital

  year unknowncites this paper